Alyeska Investment Group
PROK icon

Alyeska Investment Group’s ProKidney PROK Stock Holding History

Alyeska Investment Group’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-420,837
Closed -$4.19M – 462
2022
Q2 		$4.19M Hold
420,837
– – 0.05% 314
2022
Q1 		$4.17M Sell
420,837
-39,463
-9% -$389K 0.05% 316
2021
Q4 		$4.56M Hold
460,300
– – 0.05% 300
2021
Q3 		$4.51M Sell
460,300
-39,700
-8% -$391K 0.06% 350
2021
Q2 		$5.05M Buy
+500,000
New +$5.05M 0.06% 337

Other funds holding PROK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Alyeska Investment Group's PROK Position: Q3 2022 in Review

Alyeska Investment Group sold out of ProKidney (PROK) in Q3 2022, closing a stake of 420,837 shares — an estimated $4.19M sold.

Alyeska Investment Group first reported a position in PROK in Q2 2021 and held it in 5 quarters. The position peaked at $5.05M in Q2 2021. 18 funds tracked by Wall St. Rank hold PROK as of Q3 2022.

  • Alyeska Investment Group reported no remaining ProKidney position as of Q3 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 420,837 ProKidney shares in Q3 2022, an estimated $4.19M.
  • Alyeska Investment Group first reported a position in ProKidney in Q2 2021 and held it in 5 quarters.
  • Alyeska Investment Group's ProKidney position peaked at $5.05M in Q2 2021.
  • 18 funds tracked by Wall St. Rank held ProKidney as of Q3 2022.

Based on Alyeska Investment Group's 13F filing for Q3 2022, filed 14 Nov 2022.